Vaccine panel conflicts at historic low when Kennedy fired members
Kennedy had said, based on findings from a 2007 report, that the Advisory Committee on Immunization Practices (ACIP) was rife with conflicts. The new study published in JAMA found that between 2000 and 2024, ACIP's annual reported conflict of interest rate declined from 42.8% to 5%.
ACIP advises on which groups of people should take each vaccine approved by the U.S. Food and Drug Administration, and when they should be administered.
Conflict of interest rates on the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), which advises the agency on whether to approve vaccines, have remained below 4% since 2010, including 10 years when it was 0%, the researchers also found.
The most frequently reported conflict of interest was funding for research, which is generally considered less concerning than financial ties associated with personal income, the researchers said.
The prevalence of conflicts related to personal income – such as from consulting, royalties, or stock ownership – had been below 1% for both committees since 2016.
'In the past, there have been high levels of reported conflicts on influential vaccine committees, but there has been substantial progress since the early 2000s,' study leader Genevieve Kanter of the Schaeffer Center at the University of Southern California said in a statement.
'Secretary Kennedy is right that conflict of interest is an important issue, but he is wrong that it is present at substantial levels on (U.S. Department of Health and Human Services) vaccine advisory committees,' co-author Peter Lurie, president of the Center for Science in the Public Interest and former FDA associate commissioner, said in a statement.
Responding to the study, Department of Health and Human Services press secretary Emily Hilliard said, 'Secretary Kennedy is committed to eliminating both real and perceived conflicts to strengthen confidence in public health decisions.' Earlier this year, the agency launched its ACIP Conflicts of Interest Disclosures tool, she noted. - Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 minutes ago
- The Sun
Prologue By SL Aesthetic Group Opens at Ngee Ann City: Integrating Lifestyle Medicine with Specialised Women's Care
SINGAPORE - Media OutReach Newswire - 20 August 2025 - Recognising a crucial need for a more holistic and personalised approach to healthcare, SL Aesthetic Group announced the launch of Prologue at Ngee Ann City. The healthcare facility comprises two complementary entities: Prologue The Lifestyle Medical Clinic, which provides lifestyle medicine and preventive care services for families, and Prologue Centre for Women's Wellness, a dedicated sanctuary for women's health needs, including postpartum and menopause symptom management. In alignment with Singapore's recognition as a Blue Zone—where people live healthier and longer than average—Prologue puts overlooked lifestyle habits at the forefront of personal health management. At its core, the concept is built on the philosophy that healthcare should begin long before illness, focusing on key lifestyle principles such as stress management, quality sleep, and balanced nutrition, as seen in the world's longest-living communities. Prologue The Lifestyle Medical Clinic operates as a primary care clinic that empowers individuals to take control of their long-term health through a data-backed, prevention-first approach. The clinic focuses on the cornerstones of well-being: nutrition, sleep, stress resilience, and physical activity. This methodology helps manage health from its very foundation, with personalised care plans supported by complementary diagnostic tools. Key services include in-depth health screenings using BIA (Bioelectrical Impedance Analysis) devices for precise body composition assessment, alongside essential family healthcare services such as vaccinations and weight management programmes. Notably, Prologue is among the early adopters in Singapore of ReCOGnAIze™, an AI-powered tool for early dementia screening, demonstrating its commitment to incorporating technology in preventive healthcare. Prologue Centre for Women's Wellness provides a discreet and deeply supportive environment for women navigating the pivotal, and often underserved, transitions of postpartum recovery, perimenopause and menopause. Support for mothers includes professional care for common yet often overlooked concerns: pelvic floor health, nutritional optimisation, and guidance for fatigue and stress management. For women navigating perimenopause and menopause, the centre offers personalised guidance for hormonal balance, helping them manage metabolic changes, restore restful sleep, and navigate changes in body image and intimacy with confidence. The centre provides access to FDA-cleared, non-invasive technologies such as EXION, Embody, and EMSELLA for services related to skin laxity, vaginal health, and body contouring. This philosophy of integrated, purposeful care is the driving force behind Prologue. 'At SL Aesthetic Group, we've always believed in adapting to the needs of our patients,' says Dr. Kelvin Chua, Founder and Senior Medical Director of Prologue. 'Prologue reflects our commitment to delivering integrated medical and wellness care. We aim to support individuals in their holistic health journeys and provide women with access to personalised, evidence-based care across different stages. This represents a shift in how we approach long-term health—offering proactive care that starts well before symptoms appear.' Prologue is located at 391 Orchard Road, #05-25A/25B Ngee Ann City Podium Block, Singapore 238872. For more information about Prologue and its services, visit
The Sun
11 hours ago
- The Sun
US recalls Indonesian shrimp over radioactivity scare
WASHINGTON: United States health authorities announced a major frozen shrimp recall over potential radioactive contamination concerns. The Food and Drug Administration identified imported seafood from Indonesian company PT. Bahari Makmur Sejati as the source. Walmart supermarkets distributed the potentially affected products across thirteen American states. Radioactive isotope Cesium 137 detection triggered the precautionary recall measure. FDA officials emphasized the detected radioactivity levels remain minimal for immediate health risks. The agency confirmed no actually contaminated shrimp reached store shelves yet. However, improper handling conditions created potential contamination possibilities. Long-term consumption of even low-dose Cesium carries elevated cancer risks. This scientific understanding motivated the aggressive recall strategy. Walmart cooperated fully with authorities to remove all suspect products immediately. Consumers who purchased these specific shrimp batches should discard them immediately. The FDA continues monitoring all imports from the identified Indonesian supplier. Additional testing protocols will prevent future contamination incidents. No illnesses have been reported connected to the recalled products thus far. - AFP
New Straits Times
11 hours ago
- New Straits Times
US recalls Indonesian shrimp over radioactivity scare
WASHINGTON: US health authorities announced Tuesday a recall of frozen shrimp potentially contaminated with radioactivity. The seafood imported from a company in Indonesia has been marketed in 13 states by retail giant Walmart, the Food and Drug Administration (FDA) said on its website. The recall follows the detection of the radioactive isotope Cesium 137 in shrimp imported through the company called PT. Bahari Makmur Sejati, the advisory said. The level of radioactivity detected was minimal and the product would not pose "an acute hazard" to consumers, the FDA said. No shrimp imported by the company and stocked for sale in US stores has tested positive for radioactivity, the agency said. But shrimp from the firm "appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with Cs-137 and may pose a safety concern." Over the long term, even low-dose Cesium exposure is linked to an elevated risk of cancer, it added. The FDA asked Walmart to stage a recall of the shrimp and urged people who already bought the product to throw it away.--AFP
